Sign Up to like & get
recommendations!
1
Published in 2023 at "Molecules"
DOI: 10.3390/molecules28093852
Abstract: Lorlatinib (LRL) is the first drug of the third generation of anaplastic lymphoma kinase (ALK) inhibitors used a first-line treatment of non-small cell lung cancer (NSCLC). This study describes, for the first time, the investigations…
read more here.
Keywords:
chloranilic acid;
microwell spectrophotometric;
charge transfer;
novel microwell ... See more keywords